BCRX Long-Term Debt
Biocryst Pharmaceuticals Inc · Long-Term Debt

BCRX Long-Term Debt
Latest reported$437.25Mperiod ending
BCRX FY Long-Term Debt ($600.00K → $437.25M)
Annual long-term debt
High-resolution chart · PNG
BCRX long-term debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 437,245,000 | |
| 805,970,000 | |
| 822,500,000 | |
| 739,083,000 | |
| 591,419,000 | |
| 248,323,000 | |
| 44,695,000 | |
| 28,075,000 | |
| 19,501,000 | |
| 25,481,000 | |
| 2,375,000 | |
| 0 | |
| 30,000,000 | |
| 30,000,000 | |
| 30,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 100,000 | |
| 300,000 | |
| 600,000 |